Since high circulating GDF15 was positively correlated with cachexia, characterized by great loss of adipose tissue and skeletal muscle (sarcopenia), in some types of cancer patients [29,30], we examined whether CPT-induced GDF15 elevation causes sarcopenia in the context of obesity in our model. Here, GDF15 is linked to sarcopenia.